We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$256M
(+10%)
Cap. Flow
+$184M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
6.67%
Holding
2,298
New
784
Increased
473
Reduced
488
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$19.5M |
| 2 |
Target
TGT
|
+$17.3M |
| 3 |
Royalty Pharma
RPRX
|
+$15.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$14.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.2M |
| 2 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$10.4M |
| 4 |
ProShares UltraPro Short QQQ
SQQQ
|
+$8.83M |
| 5 |
ProShares UltraPro S&P 500
UPRO
|
+$8.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.61% |
| 2 | Industrials | 13.75% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 12.54% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ionis Pharmaceuticals
IONS
$9.04B
| $4.34M | 0.16% |
+105,768
| New | +$4.06M |
|
152
Abercrombie & Fitch
ANF
$4.58B
| $4.33M | 0.16% |
+114,870
| New | +$3.27M |
|
153
Valmont Industries
VMI
$9.41B
| $4.26M | 0.16% |
14,620
+1,307
| +10% | +$378K |
|
154
Las Vegas Sands
LVS
$32B
| $4.19M | 0.15% |
72,231
+1,893
| +3% | +$112K |
|
155
Amgen
AMGN
$211B
| $4.17M | 0.15% |
+18,796
| New | +$4.36M |
|
156
Calix
CALX
$2.36B
| $4.17M | 0.15% |
83,487
+11,197
| +15% | +$540K |
|
|
CTLT
157
DELISTED
CATALENT, INC.
CTLT
| $4.16M | 0.15% |
+96,020
| New | +$4.22M |
|
158
Synchrony
SYF
$25B
| $4.15M | 0.15% |
122,421
+69,219
| +130% | +$2.11M |
|
159
ExxonMobil
XOM
$631B
| $4.14M | 0.15% |
38,621
+17,678
| +84% | +$1.93M |
|
160
Procore
PCOR
$7.28B
| $4.12M | 0.15% |
63,367
-54,073
| -46% | -$3.18M |
|
161
Jackson Financial
JXN
$8.57B
| $4.1M | 0.15% |
+133,902
| New | +$4.31M |
|
162
Roblox
RBLX
$35.6B
| $4.07M | 0.15% |
101,084
-64,995
| -39% | -$2.61M |
|
163
Chevron
CVX
$373B
| $4.07M | 0.15% |
25,869
+13,652
| +112% | +$2.19M |
|
164
Joby Aviation
JOBY
$7.17B
| $4.05M | 0.15% |
+395,022
| New | +$2.14M |
|
165
Prudential Financial
PRU
$43.2B
| $4.03M | 0.15% |
45,628
+35,994
| +374% | +$3.01M |
|
166
EnerSys
ENS
$6.62B
| $4.01M | 0.15% |
+36,935
| New | +$3.37M |
|
167
Lumentum
LITE
$49.9B
| $4.01M | 0.15% |
70,612
+51,122
| +262% | +$2.55M |
|
168
Tandem Diabetes Care
TNDM
$1.22B
| $4M | 0.15% |
163,170
+19,021
| +13% | +$612K |
|
169
Etsy
ETSY
$8.17B
| $3.98M | 0.15% |
47,075
-20,416
| -30% | -$1.92M |
|
170
Brady Corp
BRC
$4.62B
| $3.98M | 0.15% |
83,579
+40,458
| +94% | +$2.03M |
|
171
Boston Scientific
BSX
$69.1B
| $3.97M | 0.15% |
+73,462
| New | +$3.84M |
|
172
Allegion
ALLE
$13.7B
| $3.93M | 0.15% |
32,779
-6,227
| -16% | -$680K |
|
173
Northern Trust
NTRS
$22.2B
| $3.93M | 0.14% |
+52,993
| New | +$4.07M |
|
|
X
174
DELISTED
US Steel
X
| $3.92M | 0.14% |
156,793
+10,922
| +7% | +$254K |
|
|
GMS
175
DELISTED
GMS Inc
GMS
| $3.92M | 0.14% |
+56,623
| New | +$3.5M |
|
Similar funds
YAM
ASN
OPERF
SP
AMH
BIM
CCM
GJL
Jump Financial's Q2 2023 Portfolio in Review
As of Q2 2023, Jump Financial held 2,298 positions worth $2.71B, up 10% from $2.46B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Jump Financial deployed $184M of net new capital in Q2 2023, opening 784 new positions and adding to 473 existing holdings. Its largest new stake was Royalty Pharma: 456,285 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $12.2M trimmed.
- Jump Financial's largest Q2 2023 buy was Royalty Pharma: 456,285 shares worth $14M.
- Jump Financial added most to State Street Utilities Select Sector SPDR ETF in Q2 2023, an estimated $19.5M increase.
- Jump Financial's biggest Q2 2023 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $12.2M.
- Jump Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q2 2023, selling an estimated $11M.
- Jump Financial's ten largest holdings make up 6.7% of its $2.71B portfolio in Q2 2023.
- Jump Financial opened 784 new positions and closed 552 in Q2 2023.
- Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.71B.
Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.